Wells Fargo Strategic Capital (WFSC) focuses on providing structured financing, including both equity and debt, to small and mid-cap companies in the United States and Canada. Their investment capabilities span project/development financing, mezzanine financing, and other subordinated debt financing, as well as equity financing through preferred and common stock. WFSC partners with companies across their entire lifecycle, offering venture capital and growth equity primarily to early-stage technology and healthcare businesses. Typical investment rounds include Series A through Series E, with notable activity in Series B, C, and D.
WFSC's portfolio includes prominent companies such as 10x Genomics, BigPanda, Greenlight, and Socure. The firm leverages the extensive resources of Wells Fargo to provide creative, customizable investment solutions that help businesses thrive. Key decision-makers at WFSC bring significant expertise from their affiliations with Wells Fargo & Company, ensuring a robust support system for portfolio companies. WFSC offers unique value-add services, including access to Wells Fargo's vast network and financial expertise, which aid in the strategic growth and development of their investments.
Wells Fargo Strategic Capital - Portfolio Snapshot
Portfolio activity breakdown across disclosed investments and stages
Top Investment Stages
Stage Mix
Concentration shown as share of disclosed investments by stage.

Wells Fargo Capital Finance
Wells Fargo Energy Capital

Foresite Capital

Fundamental Capital

Structural Capital

FrontWell Capital Partners

WRF Capital
wrfseattle.org

W3Capital
w3cap.com

Powers Capital
powers-capital.com
Well Ventures

Fog City Capital
fogcitycapital.com

Wells Investment
investwells.com

Strandview Capital
strandview.com

Stratim Capital
stratimcapital.com

W Capital Partners
wcapgroup.com